FASN has been shown to up-regulate PARP1 expression, contributing to increased NHEJ repair of double-strand DNA breaks and, thus, resistance to DNA damage-induced cell death32 and inhibiting FASN expression or activity sensitizes cancer cells to these treatments12,16 (Fig. 7A). The gene discussed is PARP1; the disease is cancer.